NL-OMON28143
Not yet recruiting
Not Applicable
EvaluaTion of Clinical and laboratory outcomes of Rivaroxaban in short Bowel syndrome patients dEpending on Long term parenteral nutrition: a prospective cohort study
Amsterdam University Medical Center0 sites30 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Amsterdam University Medical Center
- Enrollment
- 30
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
Exclusion Criteria
- •3\. Exclusion criteria
- •A potential subject who meets any of the following criteria will be excluded from participation in this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Evaluation of how well rivaroxaban is absorbed in patients with short bowel syndrom, based on laboratory markers and clinical outcomes such as thrombosis and bleeding.EUCTR2018-001845-15-NLAcademic medical centre, department of internal medicine30
Recruiting
Phase 4
EvaluaTIoN of Clinical and laboratory outcomes of Rivaroxaban in short Bowel syndrome patients dEpending on Long term parenteral nutrition: a prospective cohort study (TINCRBEL study)short bowel syndrome1002547710014523NL-OMON48704Vasculaire Geneeskunde30
Completed
Phase 2
A comparative clinico-experimental evaluation of Rasayana Drugs administered orally & by Basti in the management of Madhumeha w. s. r. to Type-II Diabetes MellitusHealth Condition 1: null- Type 2 Diabetes MellitusCTRI/2013/05/003705Institute for post graduate teaching and research in Ayurveda Gujarat Ayurved University Jamnagar100
Not yet recruiting
Phase 2
A clinical trial to study the effects photodynamic therapy in patients with gum diseases.CTRI/2024/06/068905Shweta S Patil
Recruiting
Phase 4
Treatment of gum loss in gum disease individuals using animal derived membrane along with patients blood derived substancesHealth Condition 1: K060- Gingival recessionCTRI/2024/05/067734kiran choudhary